NCT07517705 2026-04-08
MRD-Adapted Low-Dose Radiation Therapy During Frontline Chemoimmunotherapy for Diffuse Large B-Cell Lymphoma
University of Nebraska
Phase NA Not yet recruiting
Clinical Trials
11 trialsNCT07443592 2026-03-02
LAL-2025
PETHEMA Foundation
Phase NA Not yet recruiting
NCT07413146 2026-02-17
Neoadjuvant CAPEOX Versus Upfront Surgery for Locally Advanced Colon Cancer With Elevated CEA: A Single-Center, Open-Label, Randomized Controlled Trial
Sun Yat-sen University
Phase NA Not yet recruiting
NCT06693830 2026-01-23
ctDNA-guided Therapy Optimization in Newly Diagnosed DLBCL
Columbia University
Phase NA Recruiting
NCT07350824 2026-01-20
Predictive Value of Minimal Residual Disease for Postoperative Recurrence and Adjuvant PD-1 Inhibitor in HCC
Tongji Hospital
Phase NA Not yet recruiting
NCT07025785 2026-01-15
Molecular Residual Disease Assessment in a Representative Diverse Population of Patients With Early-stage Breast Cancer
UNC Lineberger Comprehensive Cancer Center
Phase NA Recruiting
NCT06744075 2025-12-30
CELERITY
Centre Henri Becquerel
Phase NA Active not recruiting
NCT07178847 2025-12-01
NeckTAR-IN
Centre Jean Perrin
Phase NA Recruiting
NCT07131059 2025-08-20
MRD-positive AML Clinical Study
Institute of Hematology & Blood Diseases Hospital, China
Phase NA Recruiting
NCT07003737 2025-06-04
Blinatumomab Intensification for MRD-Negative Acute B-Cell Lymphoblastic Leukemia Before Allogeneic Hematopoietic Stem Cell Transplantation
First Affiliated Hospital of Zhejiang University
Phase NA Recruiting
NCT06936345 2025-04-20
Effective Treatments for Dizziness After BPPV: A Clinical Study
Medipol University
Phase NA Completed